Özge Özgen-Top

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Intensive Care Unit

Ejection Fraction

Top Venues

Infectious diseases & clinical microbiology

BMC infectious diseases

Journal of chemotherapy (Florence, Italy)

This page only lists publications with an associated author ORCID identifier.

Publications

Pınar Aysert-Yıldız, Özge Özgen-Top, Ahmet Furkan Şentürk, Sait Kanik, Hasan Selçuk Özger, Murat Dizbay
Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins. BMC infectious diseases 24 (1) (2024)
Pınar Aysert-Yıldız, Özge Özgen-Top, Ahmet Furkan Şentürk, Sait Kanik, Hasan Selçuk Özger, Murat Dizbay
Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins. BMC infectious diseases 24 (1) (2024)
Özge Özgen-Top, Pınar Aysert-Yıldız, Hasan Selçuk Özger, Özlem Güzel Tunçcan
Evaluation of Hospitalized Patients with Community-Acquired Influenza-Like Illness During Two Influenza Seasons. Infectious diseases & clinical microbiology 5 (4) (2023)
Özge Özgen-Top, Pınar Aysert-Yıldız, Hasan Selçuk Özger, Özlem Güzel Tunçcan
Evaluation of Hospitalized Patients with Community-Acquired Influenza-Like Illness During Two Influenza Seasons. Infectious diseases & clinical microbiology 5 (4) (2023)
Pınar Aysert-Yıldız, Yeşim Yıldız, Hamid Habibi, Sedanur Eser, Özge Özgen-Top, Hasan Selçuk Özger, Murat Dizbay
Stenotrophomonas maltophilia Bacteremia: From Diagnosis to Treatment. Infectious diseases & clinical microbiology 4 (4) (2022)
Pınar Aysert-Yıldız, Yeşim Yıldız, Hamid Habibi, Sedanur Eser, Özge Özgen-Top, Hasan Selçuk Özger, Murat Dizbay
Stenotrophomonas maltophilia Bacteremia: From Diagnosis to Treatment. Infectious diseases & clinical microbiology 4 (4) (2022)
Pınar Aysert-Yıldız, Özge Özgen-Top, Hamid Habibi, Murat Dizbay
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae . Journal of chemotherapy (Florence, Italy) (2022)